American Academy of Child and Adolescent Psychiatry 59th Annual Meeting Program Schedule
Please note that this schedule is subject to change.

New Research Poster Presentation 3.50
Acute and Longer-Term Safety Results From a Pooled Analysis of Duloxetine Studies for the Treatment of Children (7-11 Years) and Adolescents (12-17 Years) with Major Depressive Disorder
Thursday, October 25, 2012
John S. March, M.D., M.P.H., Duke Clinical Research Institute, Durham, NC
Thomas G. Wells, MD, Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR
Apurva Prakash, B.A., Eli Lilly and Company, Indianapolis, IN
Qi Zhang, PhD, Eli Lilly and Company, Indianapolis, IN
Beth A. Pangallo, RN, Eli Lilly and Company, Indianapolis, IN
Mark E. Bangs, M.D., Eli Lilly and Company, Indianapolis, IN
Graham J. Emslie, M.D., UT Southwestern Medical Center at Dallas, Dallas, TX
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.